Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide

Diabetes

Volumn 47, Issue 5, 1998, Pages 743-750

  Soeller, Walter C ^a   Janson, Juliette ^b   Hart, Susan Emeigh ^a   Parker, Janice C ^a   Carty, Maynard D ^a   Stevenson, Ralph W ^a   Kreutter, David K ^a   Butler, Peter C ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN;

ANIMAL TISSUE; ARTICLE; CYTOTOXICITY; DIABETES MELLITUS; HISTOPATHOLOGY; HYPERGLYCEMIA; INNER CELL MASS; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGING; AMYLOID; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; FEMALE; GENOTYPE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; PHENOTYPE;

EID: 0031920985     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.743     Document Type: Article

References (31)

1. DeFronzo R, Deibert D, Hendler R, Felig P, Soman V: Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest 63:939-946, 1979
2. Kahn CR: Insulin action, diabetogenes and the cause of type 2 diabetes. Diabetes 43:1066-1084, 1994
3. Polonsky KS, Sturis J, Bell GI: Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the β cell to compensate for insulin resistance. N Engl J Med 334:777-783, 1996
4. Howard CF: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29:301-306, 1986
5. Clark A, Charge SBP, Badman MK, De Koning EJP: Islet amyloid in type 2 (non-insulin-dependent) diabetes. APMIS 104:12-18, 1996
6. Röcken C, Linke RP, Saeger W: Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch A Pathol Anat Histopathol 421:339-344, 1992
7. Maloy AL, Longnecker DS, Greenberg ER: The relation of islet amyloid to the clinical type of diabetes. Hum Pathol 12:917-922, 1981
8. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH: Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127:414-417, 1987
9. Cooper GJ, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KB: Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 85:7763-7766, 1988
10. Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:7283-7288, 1996
11. Couce M, Kane LA, O'Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and β-cell dysfunction. Diabetes 45:1094-1101, 1996
12. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic β cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:3492-3496, 1996
13. Saad MF, Knowler WC, Pettit DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1516, 1988
14. Conn J, Fajans S: Symposium on diabetes: influence of adrenal cortisol steriods on carbohydrate metabolism in man. Metabolism 5:114-120, 1956
15. Butler PC, Eberhardt NL, O'Brien TD: Islet Amyloid Polypeptide (IAPP) and Insulin Secretion. Totowa, NJ, Humana, 1994, p. 381-398
16. O'Brien TD, Butler AE, Johnson KH, Roche PC, Butler PC: Islet amyloid polypeptide (IAPP) in human insulinomas: evidence for intracellular amyloidogenesis. Diabetes 43:329-336, 1994
17. Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS: Neomorphic agouti mutations in obese yellow mice. Nat Genet 8:59-65, 1994
18. Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL: Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB 8:479-488, 1994
19. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP: Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 92:4728-4732, 1995
20. Bancroft JD, Cook HC: Manual of Histochemical Techniques and Their Diagnostic Application. New York, Churchill Livingstone, 1994, p. 117-120
21. Hellerström C, Hellman B: The islets of Langerhans in yellow obese mice. Metabolism 12:527-536, 1963
22. vy- mice: relation to adult hyperinsulinemia and obesity. Proc Soc Exp Biol Med 206:145-151, 1994
23. Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC: Islet amyloid formed from diabetes associated peptide may be pathogenic in type 2 diabetes. Lancet 11:231-234, 1987
24. Yagui K, Yamaguchi T, Kanatsuka A, Shimada F, Huang C, Tokuyama Y, Ohsawa H, Yamamura K, Miyazaki J, Mikata A, Yoshida S, Makino H: Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin. Eur J Endocrinol 132:487-496, 1995
25. Caughey B, Chesebro B: Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol 7:56-62, 1997
26. Aitman TJ, Todd JA: Molecular genetics of diabetes mellitus. Baillieres Clin Endocrinol & Metab 9:631-656, 1995
27. Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman JA, Westermark GT, Leckstrom A, Westermark P, Steiner DF: Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323:40-44, 1993
28. Höppener JW, Verbeek JS, de Koning EJ, Oosterwijk C, van Hulst KL, Visser- Vernooy HJ Hofhuis FM, van Gaalon S, Berends MJ, Hackeng WH, Jansz HS, Morris JF, Clark A, Capel PJ, Lips CJM: Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomol localization of human islot amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinemia. Diabetologia 36:1258-1265, 1993
29. Silvestre RA, Salas M, Rodriguezgallardo J, Garciahermida O, Fontela T, Marco J: Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin. glucagon and somatostatin release-study in the perfused pancreas of the rat. Br J Pharmacol 117:347-350, 1996
30. Young AA, Carlo P, Rink TJ, Wang MW: 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol Cell Endocrinol 84:R1-R5, 1992
31. Soeller W, Parker J, Janson J, Nelson R, Carty M, Torchia A, Orena S, Stock J, McNeish J, Stevenson R, Kreutter D: Two distinct diabetogenic roles for IAPP revealed by elevated expression of human and rodent homologues in transgenic mice (Abstract). Diabetes 45 (Suppl. 2):161A, 1996